Found 13 matching trials
SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC NA This is a Prospective, Multicenter, Randomized Controlled study to evaluate...
Show More Location
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430030, Hubei, P. R. China
Learn More & Join Trial
Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC PHASE2 This open-label, multicenter, randomized phase II study will evaluate the u...
Show More Status
Active Not Recruiting
Location
BC Cancer, Vancouver Centre
Learn More & Join Trial
Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC N/A The goal of this observational study is to explore the feasibility of stere...
Show More Location
Wuhan Tongji Hospital
Learn More & Join Trial
Efficacy and Safety of Platinum-based Chemotherapy + Bevacizumab + Durvalumab, and Salvage SBRT for IV Non-Small Cell Lung Cancer Patients With EGFR Mutations After Failure of First Line Osimertinib: A Multicenter, Prospective, Phase II Clinical Study PHASE2 Lung cancer still occupies the highest incidence and mortality rate in the ...
Show More Location
Fudan University shanghai cancer center
Learn More & Join Trial
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer PHASE3 This phase III trial compares the effect of adding stereotactic body radiat...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases N/A The goal of this retrospective real-world study is to evaluate the effectiv...
Show More Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation PHASE3 This is a Phase III, randomized, placebo-controlled, double-blind, multi-ce...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO) NA Phase II Study to Evaluate the Impact of SBRT (Stereotactic Body Radiation ...
Show More Location
CTIC - Centro de Tratamiento e Investigación Sobre Cáncer Luis Carlos Sarmiento Angulo
Learn More & Join Trial
Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer PHASE2 This is an open-label, multicentre, randomized phase II clinical trial. Pat...
Show More Location
Department of Clinical Oncology, Prince of Wales Hospital
Learn More & Join Trial
SRT for Residual Oligometastases of NSCLC After 3rd Generation EGFR-TKIs PHASE2 This study is an open-label, single-arm phase 2 trial to evaluate the effic...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial